The Summit on Breakthrough Therapies for Addiction

arrow_back View All Dates

7:45am EDT

Breakfast & Registration

8:55am EDT

IntroductionsBen Greenzweig

9:00am EDT

Welcoming RemarksAlon Z. Weizer, MD, MS

9:10am EDT

Chair’s Opening RemarksOwen Muir, MD

9:15am EDT

Beginning of CME Content Opening Keynote Panel: The Current State of Breakthrough Therapies for AddictionJose Cruz, MD • Caroline Elistin, DNP, MSN-Ed, AAPRN, FNP-BC, PMHNP-BC • Richard Seely, MD

10:15am EDT

Unraveling The Relationship Between Pain and AddictionMichelle Weiner, DO, MPH

11:00am EDT

End of CME Content Morning Break

11:30am EDT

Semaglutide: A Peptide Provides HopeWarren K. Bickel, Ph.D.

12:00pm EDT

First Look at Real-World Evidence: Preliminary Results from OSU's Ibogaine Treatment RegistryStacey Armstrong, PhD

12:45pm EDT

Lunch

2:00pm EDT

Beginning of CME Content Efficacy of Ketamine in the Treatment of Substance Use DisordersJennifer L. Jones, MD • Elias Dakwar, MD

2:45pm EDT

Psilocybin: A Promising Approach to Addiction TreatmentPeter Hendricks, PhD

3:30pm EDT

Exploring the Future of Breakthrough Therapies for Addiction: Research, Applications, and ScalabilityOwen Muir, MD • Lantie Jorandby, MD • Peter Hendricks, PhD • Charlie Panfil

4:15pm EDT

End of CME Content Afternoon Break

4:45pm EDT

Navigating MDMA Approval: Preparing Treatment Centers for Integration into Addiction Treatment and Mental Health PracticesJeeshan Chowdhury, MD, DPhil

5:30pm EDT

Closing Spotlight Session: Ibogaine and Noribogaine: Mechanisms and Therapeutic Potential for AddictionDeborah Mash, PhD

6:15pm EDT

Closing RemarksBen Greenzweig • Owen Muir, MD

6:30pm EDT

Networking Reception: Mocktails